PCV38 BOSENTAN IS A COST-EFFECTIVE TREATMENT FOR UNITED KINGDOM PATIENTS WITH PULMONARY ARTERIAL HYPERTENSION OF WHO CLASS III

May 1, 2008, 00:00
10.1016/S1098-3015(10)70626-4
https://www.valueinhealthjournal.com/article/S1098-3015(10)70626-4/fulltext
Title : PCV38 BOSENTAN IS A COST-EFFECTIVE TREATMENT FOR UNITED KINGDOM PATIENTS WITH PULMONARY ARTERIAL HYPERTENSION OF WHO CLASS III
Citation : https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(10)70626-4&doi=10.1016/S1098-3015(10)70626-4
First page :
Section Title :
Open access? : No
Section Order : 356
Categories :
Tags :
Regions :
ViH Article Tags :